Dr. Agarwal's Health Care Limited (BOM:544350)

India · Delayed Price · Currency is INR

488.15

+4.30 (0.89%)

At close: Oct 6, 2026

Market Cap	154.34B -2.3%
Revenue (ttm)	22.07B +22.9%
Net Income	1.48B +46.1%
EPS	4.65 +41.8%
Shares Out	n/a
PE Ratio	104.03
Forward PE	73.40
Dividend	n/a
Ex-Dividend Date	n/a

Volume	56,702
Open	485.00
Previous Close	483.85
Day's Range	474.10 - 488.95
52-Week Range	402.10 - 567.80
Beta	n/a
Analysts	Strong Buy
Price Target	584.60 (+19.76%)
Est. Earnings	Nov 20, 2026

About Dr. Agarwal's Health Care

Dr. Agarwal's Health Care Limited engages in running, owning, and managing eye care hospitals, opticals, pharmacies, etc. and related services in India and internationally. It offers femto cataracts, lenticular procedure, retinal surgeries, anterior segment reconstruction, and corneal transplants, as well as refractive and other surgeries. The company also develops, designs, manufactures, imports, and exports healthcare devices, which include ophthalmic diagnostic devices, such as auto perimeter, optical biometers, and ophthalmoscopes. In addit... [Read more]

Industry Health Services

Founded 2010

Country India

Stock Exchange Bombay Stock Exchange

Ticker Symbol 544350

Full Company Profile

Financial Performance

In fiscal year 2026, Dr. Agarwal's Health Care's revenue was 20.80 billion, an increase of 21.57% compared to the previous year's 17.11 billion. Earnings were 1.33 billion, an increase of 59.59%.

Financial Statements

Analyst Summary

According to 5 analysts, the average rating for 544350 stock is "Strong Buy." The 12-month stock price target is ₹584.60, which is an increase of 19.76% from the latest price.

Price Target

₹584.60

(19.76% upside)

Analyst Consensus: Strong Buy

Stock Forecasts